Ben C Askew

Title: Innovator Spotlight: Ben C. Askew from Marshfield, MA

Introduction: Ben C. Askew, an accomplished inventor based in Marshfield, MA, holds an impressive portfolio of 50 patents. His contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic potentials, have marked significant advancements in medical science.

Latest Patents: Among his latest innovative works are two pivotal patents. The first patent describes “Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives,” which focuses on these compounds as KCNQ2/3 potassium channel modulators, providing new methods for their application in healthcare. The second patent involves “Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof.” This invention not only details the synthesis of these fluorinated compounds but also explores their pharmaceutical applications for treating conditions such as fibrosis, macular degeneration, diabetic retinopathy, and other related ocular disorders.

Career Highlights: Ben C. Askew has made significant strides in his career, contributing to the pharmaceutical sector through his work in various organizations. He has been associated with Scifluor Life Sciences, Inc. and Kala Pharmaceuticals, Inc., where his innovative ideas have been translated into valuable patent applications.

Collaborations: Throughout his career, Ben has collaborated with notable professionals, including Takeru Furuya and Mark E. Duggan. These partnerships have fostered a collaborative spirit that fuels innovation and the development of groundbreaking therapeutic solutions.

Conclusion: Ben C. Askew exemplifies the essence of innovation through his extensive patent portfolio and collaborations within the pharmaceutical industry. His work continues to inspire the next generation of inventors while contributing significantly to advancements in medical science.